Cardiology ranked No. 10 among all specialties, with plastic surgery and surgery tied at No. 1. 

A new study in Science Signaling could have significant ramifications for how we view obesity-related cancers.

The study tracked five generic statins: atorvastatin, rosuvastatin, simvastatin, lovastatin and pravastatin.

The authors also noted that cardiac complications such as myocarditis, MI and new-onset heart failure were rare during hospitalization for COVID-19.

The study, published in the Journal of the American College of Cardiology, examined outcomes from more than 3,000 patients. 

No such trend was reported among patients with end-stage kidney disease.

Doctors may not want to prescribe aspirin to patients presenting with obesity, high blood pressure, diabetes or a number of other risk factors.

Researchers focused on rates of venous thromboembolism among COVID-19 patients at their own health system, sharing their work in JAMA Network Open.

The full analysis was published in Circulation: Heart Failure. 

The Disrupt BTK II study will include 250 patients overall.